Cytokinetics (CYTK): are the analysts right?

Cytokinetics · Health Care · ref. ETF XLV · 82 calls · price $85.86
What the company does: Cytokinetics développe et commercialise des molécules activatrices et inhibitrices musculaires thérapeutiques.
📈 1-year price
$85.56+149.8% over range
Jul 8, 25low $33.23 · high $87.26Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
93% recommend buying · 15 analysts

🎯 Analyst price target on CYTK

High target · 1 analyst$140+63.1%
Median target · 15 analysts$102+18.8%
Low target · 1 analyst$69-19.6%
Current price$85.86

🗳️ The analyst consensus

Analyst breakdown · 15 (6 months)
Strong Buy0%
Buy93%
Hold7%
Sell0%
Strong Sell0%

✅ Historical analyst reliability on CYTK

Most reliable analysts on CYTK (% profitable · 365j · ≥2 calls)
HC Wainwright & Co. 100% +43.6% 12
Cantor Fitzgerald 89% +52.0% 9
Needham 58% +21.1% 12

📊 What $1,000 invested in Cytokinetics would be worth

In short — $1,000 invested in Cytokinetics 10 years ago would be worth $8,144 today, i.e. +23%/yr on average. Best year: 2021 (+119%), worst: 2024 (-44%). Price performance, excluding dividends.

If I'd invested $1,000 in Cytokinetics

InvestmentWorth todayGain
1 years ago$1,811+81%
3 years ago$1,859+86%
5 years ago$4,100+310%
10 years ago$8,144+714%
since inception (2004)$866-13%

Return by year (Cytokinetics)

YearReturn$1,000 invested at year start
2026 (YTD)+34%$1,341 (+34%)
2025+35%$1,811 (+81%)
2024-44%$1,020 (+2%)
2023+82%$1,859 (+86%)
2022+1%$1,869 (+87%)
2021+119%$4,100 (+310%)
2020+96%$8,029 (+703%)
2019+68%$13,479 (+1248%)
2018-22%$10,453 (+945%)
2017-33%$7,012 (+601%)
2016+16%$8,144 (+714%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on CYTK

Mizuho
Jun 24, 26
▲ Outperform · 🎯$118
Price at call : $81.2 — upside +45%
Today : $85.86 — upside +37%
🎯 on CYTK : 100% (1 call matured) · 📊 on Health : 58.2% · +13.7% (55 calls)
in progress (365j)
matures : Jun 24, 27
Needham
Jun 17, 26
▲ Buy · 🎯$102
Price at call : $78.11 — upside +31%
Today : $85.86 — upside +19%
🎯 on CYTK : 58% (12 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
in progress (365j)
matures : Jun 17, 27
Citigroup
May 19, 26
▲ Buy · 🎯$99
Price at call : $78.77 — upside +26%
Today : $85.86 — upside +15%
🎯 on CYTK : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : May 19, 27
JP Morgan
May 12, 26
▲ Overweight · 🎯$97
Price at call : $77.22 — upside +26%
Today : $85.86 — upside +13%
🎯 on CYTK : 100% (1 call matured) · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : May 12, 27
▲ Buy · 🎯$140
Price at call : $74.56 — upside +88%
Today : $85.86 — upside +63%
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : May 11, 27
Wells Fargo
May 7, 26
▲ Overweight · 🎯$105
Price at call : $76.91 — upside +37%
Today : $85.86 — upside +22%
🎯 on CYTK : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : May 7, 27
Stifel
May 6, 26
▲ Buy · 🎯$108
Price at call : $74.29 — upside +45%
Today : $85.86 — upside +26%
🎯 on CYTK : no call matured yet · 📊 on Health : 47.2% · +12.4% (89 calls)
in progress (365j)
matures : May 6, 27
▲ Overweight · 🎯$103
Price at call : $74.29 — upside +39%
Today : $85.86 — upside +20%
🎯 on CYTK : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : May 6, 27
RBC Capital
May 6, 26
▲ Outperform · 🎯$119
Price at call : $74.29 — upside +60%
Today : $85.86 — upside +39%
🎯 on CYTK : 100% (1 call matured) · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : May 6, 27
Needham
May 5, 26
▲ Buy · 🎯$102
Price at call : $74.84 — upside +36%
Today : $85.86 — upside +19%
🎯 on CYTK : 58% (12 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
in progress (365j)
matures : May 5, 27
Wells Fargo
Apr 10, 26
▲ Overweight · 🎯$95
Price at call : $66.72 — upside +42%
Today : $85.86 — upside +11%
🎯 on CYTK : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Apr 10, 27
Barclays
Apr 6, 26
▲ Overweight · 🎯$95
Price at call : $65.48 — upside +45%
Today : $85.86 — upside +11%
🎯 on CYTK : 100% (1 call matured) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Apr 6, 27
Mizuho
Mar 18, 26
▲ Outperform · 🎯$100
Price at call : $62.95 — upside +59%
Today : $85.86 — upside +16%
🎯 on CYTK : 100% (1 call matured) · 📊 on Health : 58.2% · +13.7% (55 calls)
in progress (365j)
matures : Mar 18, 27
JP Morgan
Mar 17, 26
▲ Overweight · 🎯$75
Price at call : $62.19 — upside +21%
Today : $85.86 — upside -13%
🎯 on CYTK : 100% (1 call matured) · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Mar 17, 27
UBS
Mar 6, 26
■ Neutral neutral · not a buy · 🎯$69
Price at call : $62.42 — gap to target +11%
Today : $85.86 — gap to target -20%
🎯 on CYTK : no call matured yet · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Mar 6, 27
▲ Outperform · 🎯$84
Price at call : $62.22 — upside +35%
Today : $85.86 — upside -2%
🎯 on CYTK : no call matured yet · 📊 on Health : 44.4% · -4.7% (9 calls)
in progress (365j)
matures : Feb 26, 27
Citizens
Feb 25, 26
▲ Market Outperform · 🎯$96
Price at call : $62.89 — upside +53%
Today : $85.86 — upside +12%
🎯 on CYTK : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Feb 25, 27
Needham
Feb 25, 26
▲ Buy · 🎯$85
Price at call : $62.89 — upside +35%
Today : $85.86 — upside -1%
🎯 on CYTK : 58% (12 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
in progress (365j)
matures : Feb 25, 27
RBC Capital
Feb 20, 26
▲ Outperform · 🎯$101
Price at call : $67.94 — upside +49%
Today : $85.86 — upside +18%
🎯 on CYTK : 100% (1 call matured) · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Feb 20, 27
▲ Buy · 🎯$92
Price at call : $64.73 — upside +42%
Today : $85.86 — upside +7%
🎯 on CYTK : no call matured yet · 📊 on Health : 62% · +8.5% (92 calls)
in progress (365j)
matures : Feb 3, 27
▲ Buy · 🎯$108
Price at call : $64.93 — upside +66%
Today : $85.86 — upside +26%
🎯 on CYTK : no call matured yet · 📊 on Health : 50% · +21.5% (22 calls)
in progress (365j)
matures : Jan 21, 27
RBC Capital
Jan 21, 26
▲ Outperform · 🎯$95
Price at call : $64.93 — upside +46%
Today : $85.86 — upside +11%
🎯 on CYTK : 100% (1 call matured) · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Jan 21, 27
JP Morgan
Jan 20, 26
▲ Overweight · 🎯$74
Price at call : $63.04 — upside +17%
Today : $85.86 — upside -14%
🎯 on CYTK : 100% (1 call matured) · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Jan 20, 27
▲ Overweight · 🎯$71
Price at call : $64.18 — upside +11%
Today : $85.86 — upside -17%
🎯 on CYTK : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Dec 23, 26
RBC Capital
Dec 22, 25
▲ Outperform · 🎯$95
Price at call : $65.6 — upside +45%
Today : $85.86 — upside +11%
🎯 on CYTK : 100% (1 call matured) · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Dec 22, 26
Barclays
Dec 22, 25
▲ Overweight · 🎯$87
Price at call : $65.6 — upside +33%
Today : $85.86 — upside +1%
🎯 on CYTK : 100% (1 call matured) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Dec 22, 26
Citizens
Dec 22, 25
▲ Market Outperform · 🎯$88
Price at call : $65.6 — upside +34%
Today : $85.86 — upside +2%
🎯 on CYTK : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Dec 22, 26
Needham
Dec 22, 25
▲ Buy · 🎯$84
Price at call : $65.6 — upside +28%
Today : $85.86 — upside -2%
🎯 on CYTK : 58% (12 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
in progress (365j)
matures : Dec 22, 26
▲ Buy · 🎯$136
Price at call : $65.6 — upside +107%
Today : $85.86 — upside +58%
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Dec 22, 26
Goldman Sachs
Dec 19, 25
▲ Buy · 🎯$95
Price at call : $65.6 — upside +45%
Today : $85.86 — upside +11%
🎯 on CYTK : no call matured yet · 📊 on Health : 52.2% · +7.8% (90 calls)
in progress (365j)
matures : Dec 19, 26
Needham
Dec 12, 25
▲ Buy · 🎯$72
Price at call : $63.35 — upside +14%
Today : $85.86 — upside -16%
🎯 on CYTK : 58% (12 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
in progress (365j)
matures : Dec 12, 26
RBC Capital
Nov 11, 25
▲ Outperform · 🎯$87
Price at call : $65.94 — upside +32%
Today : $85.86 — upside +1%
🎯 on CYTK : 100% (1 call matured) · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Nov 11, 26
▲ Buy · 🎯$90
Price at call : $66.5 — upside +35%
Today : $85.86 — upside +5%
🎯 on CYTK : no call matured yet · 📊 on Health : 50% · +21.5% (22 calls)
in progress (365j)
matures : Nov 10, 26
Barclays
Oct 6, 25
▲ Overweight · 🎯$82
Price at call : $60.64 — upside +35%
Today : $85.86 — upside -4%
🎯 on CYTK : 100% (1 call matured) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Oct 6, 26
■ Neutral neutral · not a buy · 🎯$56
Price at call : $56.97 — gap to target -2%
Today : $85.86 — gap to target -35%
🎯 on CYTK : no call matured yet · 📊 on Health : 61.4% · +19.8% (83 calls)
in progress (365j)
matures : Oct 2, 26
▲ Buy · 🎯$120
Price at call : $54.96 — upside +118%
Today : $85.86 — upside +40%
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Sep 29, 26
▲ Buy · 🎯$80
Price at call : $48.55 — upside +65%
Today : $85.86 — upside -7%
🎯 on CYTK : no call matured yet · 📊 on Health : 50% · +21.5% (22 calls)
in progress (365j)
matures : Sep 22, 26
▲ Buy · 🎯$120
Price at call : $48.25 — upside +149%
Today : $85.86 — upside +40%
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Sep 22, 26
Barclays
Sep 3, 25
▲ Overweight · 🎯$71
Price at call : $49.75 — upside +43%
Today : $85.86 — upside -17%
🎯 on CYTK : 100% (1 call matured) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Sep 3, 26
▲ Outperform · 🎯$80
Price at call : $49.75 — upside +61%
Today : $85.86 — upside -7%
🎯 on CYTK : no call matured yet · 📊 on Health : 35.3% · -9.2% (34 calls)
in progress (365j)
matures : Sep 3, 26
Citigroup
Sep 2, 25
▲ Buy · 🎯$84
Price at call : $49.99 — upside +68%
Today : $85.86 — upside -2%
🎯 on CYTK : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : Sep 2, 26
Stifel
Sep 2, 25
▲ Buy · 🎯$96
Price at call : $49.99 — upside +92%
Today : $85.86 — upside +12%
🎯 on CYTK : no call matured yet · 📊 on Health : 47.2% · +12.4% (89 calls)
in progress (365j)
matures : Sep 2, 26
▲ Market Outperform · 🎯$78
Price at call : $49.99 — upside +56%
Today : $85.86 — upside -9%
🎯 on CYTK : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Sep 2, 26
Needham
Sep 2, 25
▲ Buy · 🎯$72
Price at call : $49.62 — upside +45%
Today : $85.86 — upside -16%
🎯 on CYTK : 58% (12 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
in progress (365j)
matures : Sep 2, 26
Citigroup
Aug 9, 25
▲ Buy · 🎯$77
Price at call : $33.23 — upside +132%
Today : $85.86 — upside -10%
🎯 on CYTK : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : Aug 9, 26
JP Morgan
Jun 9, 25
▲ Overweight · 🎯$53
Price at call : $34.54 — upside +53%
Today : $85.86 — upside -38%
Expected +53% · Actual +94% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (1 call matured) · 📊 on Health : 48.4% · +4.8% (126 calls)
+94.2%
stock +94% · XLV +13%
Mizuho
May 29, 25
▲ Outperform · 🎯$84
Price at call : $31.02 — upside +171%
Today : $85.86 — upside -2%
Expected +171% · Actual +138% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (1 call matured) · 📊 on Health : 58.2% · +13.7% (55 calls)
+137.5%
stock +138% · XLV +11%
Needham
May 14, 25
▲ Buy · 🎯$72
Price at call : $30 — upside +140%
Today : $85.86 — upside -16%
Expected +140% · Actual +162% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 58% (12 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
+162.1%
stock +162% · XLV +14%
Barclays
May 8, 25
▲ Overweight · 🎯$53
Price at call : $31.7 — upside +67%
Today : $85.86 — upside -38%
Expected +67% · Actual +135% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (1 call matured) · 📊 on Health : 47.8% · +1.6% (186 calls)
+135.2%
stock +135% · XLV +8%
RBC Capital
May 7, 25
▲ Outperform · 🎯$80
Price at call : $32.48 — upside +146%
Today : $85.86 — upside -7%
Expected +146% · Actual +137% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (1 call matured) · 📊 on Health : 48.9% · +4.9% (186 calls)
+136.8%
stock +137% · XLV +7%
Needham
May 2, 25
▲ Buy · 🎯$72
Price at call : $37.35 — upside +93%
Today : $85.86 — upside -16%
Expected +93% · Actual +77% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 58% (12 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
+76.8%
stock +77% · XLV +4%
▲ Buy · 🎯$120
Price at call : $37.81 — upside +217%
Today : $85.86 — upside +40%
Expected +217% · Actual +75% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+75.2%
stock +75% · XLV +8%
▲ Buy · 🎯$120
Price at call : $39.15 — upside +207%
Today : $85.86 — upside +40%
Expected +207% · Actual +67% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+67.1%
stock +67% · XLV +8%
Needham
Apr 8, 25
▲ Buy · 🎯$72
Price at call : $34.57 — upside +108%
Today : $85.86 — upside -16%
Expected +108% · Actual +90% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 58% (12 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
+90.3%
stock +90% · XLV +13%
▲ Buy · 🎯$120
Price at call : $37.36 — upside +221%
Today : $85.86 — upside +40%
Expected +221% · Actual +74% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+73.8%
stock +74% · XLV +8%
▲ Buy · 🎯$120
Price at call : $46 — upside +161%
Today : $85.86 — upside +40%
Expected +161% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+33.5%
stock +34% · XLV +6%
Needham
Feb 6, 25
▲ Buy · 🎯$72
Price at call : $42.76 — upside +68%
Today : $85.86 — upside -16%
Expected +68% · Actual +48% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 58% (12 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
+48.2%
stock +48% · XLV +7%
▲ Buy · 🎯$120
Price at call : $46.82 — upside +156%
Today : $85.86 — upside +40%
Expected +156% · Actual +39% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+38.7%
stock +39% · XLV +11%
▲ Buy · 🎯$120
Price at call : $46.82 — upside +156%
Today : $85.86 — upside +40%
Expected +156% · Actual +39% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+38.7%
stock +39% · XLV +11%
▲ Buy · 🎯$120
Price at call : $45.23 — upside +165%
Today : $85.86 — upside +40%
Expected +165% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+42.8%
stock +43% · XLV +13%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)